1177.HK - Sino Biopharmaceutical Limited

HKSE - HKSE Delayed Price. Currency in HKD
Currency in HKD

Valuation measures4

Market cap (intra-day) 80.69B
Enterprise value 77.35B
Trailing P/E 31.55
Forward P/E 21.83
PEG Ratio (5 yr expected) 1.24
Price/sales (ttm)2.53
Price/book (mrq)2.42
Enterprise value/revenue 2.69
Enterprise value/EBITDA 10.65

Trading information

Stock price history

Beta (5Y monthly) 0.55
52-week change 3-10.55%
S&P500 52-week change 30.07%
52-week high 35.390
52-week low 33.580
50-day moving average 34.241
200-day moving average 34.270

Share statistics

Avg vol (3-month) 337.11M
Avg vol (10-day) 339.34M
Shares outstanding 518.81B
Implied shares outstanding 6N/A
Float 89.46B
% held by insiders 147.91%
% held by institutions 114.72%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.12
Forward annual dividend yield 43.22%
Trailing annual dividend rate 30.11
Trailing annual dividend yield 32.84%
5-year average dividend yield 41.03
Payout ratio 471.67%
Dividend date 3N/A
Ex-dividend date 420 Jun 2023
Last split factor 23:2
Last split date 320 Jul 2020

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Dec 2022


Profit margin 8.84%
Operating margin (ttm)20.43%

Management effectiveness

Return on assets (ttm)5.90%
Return on equity (ttm)13.22%

Income statement

Revenue (ttm)28.78B
Revenue per share (ttm)1.54
Quarterly revenue growth (yoy)8.60%
Gross profit (ttm)N/A
Net income avi to common (ttm)2.54B
Diluted EPS (ttm)0.130
Quarterly earnings growth (yoy)-89.80%

Balance sheet

Total cash (mrq)16.92B
Total cash per share (mrq)0.92
Total debt (mrq)14.12B
Total debt/equity (mrq)37.21
Current ratio (mrq)1.29
Book value per share (mrq)1.61

Cash flow statement

Operating cash flow (ttm)6.27B
Levered free cash flow (ttm)3.29B